IGC Pharma, Inc.IGCNYSE
Loading
Revenue ContractionContracting
Percentile Rank29
3Y CAGR+47.4%
5Y CAGR-20.8%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+47.4%/yr
vs -34.8%/yr prior
5Y CAGR
-20.8%/yr
Recent acceleration
Acceleration
+82.2pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.27M | -5.5% |
| 2024 | $1.34M | +47.6% |
| 2023 | $911000.00 | +129.5% |
| 2022 | $397000.00 | -55.8% |
| 2021 | $898000.00 | -77.9% |
| 2020 | $4.07M | -20.4% |
| 2019 | $5.12M | +133.3% |
| 2018 | $2.19M | +277.9% |
| 2017 | $580372.00 | -90.9% |
| 2016 | $6.37M | - |